Need Medgate sign up and start generating revenue from clinic use, supposedly these clinic think the medical device is very useful. The wearable device for the chronic respiratory management market was mentioned in the transcript. I personally think they should delay entering this market space for a few quarters to give them total focus on commercialisation of ResAppDx and SleepCheck to an extent.
"The need for long-term monitoring of patients in clinical trials or monitoring patients with chronic disease is an important emerging opportunity for ResApp. And the initial work with ResApp's had with AstraZeneca, that's an important base. Our wearable device, which is nearing completion, is also the perfect platform for deployment of a 24/7 monitoring solution, and we look forward to providing updates on this and our handheld device during the current quarter"
